Cell therapy manufacturing and bioprocessing

CELL AND GENE THERAPY INSIGHTS

May 2025

Cell therapy manufacturing and bioprocessing

Expert Insight

Full speed ahead: how rapid CAR-T manufacturing can shape the cell therapy landscape

Full speed ahead: how rapid CAR-T manufacturing can shape the cell therapy landscape

Mackenzie Lieberman, Kathryn Henckels

Review

Technical and regulatory opportunities and challenges for cell and gene therapies in low earth orbit: a status report

Technical and regulatory opportunities and challenges for cell and gene therapies in low earth orbit: a status report

G du Moulin, I Sands, M Anne Snow et al.

Innovator Insight

Next-gen cell therapy manufacturing: leveraging flexibility and automation for success

Next-gen cell therapy manufacturing: leveraging flexibility and automation for success

David Shaw, Fred Parietti, Carl Dargitz

Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Kasey Kime, Xiao Peng

EBook

Next-gen immunotherapy: a guide for CGT developers

Next-gen immunotherapy: a guide for CGT developers

Infographic

Why choose a modular, automated approach to autologous CAR T manufacturing?

Why choose a modular, automated approach to autologous CAR T manufacturing?

Interview

Exploring strategies for scaling up allogeneic natural killer cell therapy

Exploring strategies for scaling up allogeneic natural killer cell therapy

The path to PAT: the role of process analytical technologies in advancing CAR-T therapy production

The path to PAT: the role of process analytical technologies in advancing CAR-T therapy production

Digitalization and data analytics: shaping the future of cell bioprocessing

Digitalization and data analytics: shaping the future of cell bioprocessing

Driving innovation to advance allogeneic cell therapies through manufacturing platform development

Driving innovation to advance allogeneic cell therapies through manufacturing platform development

Webinars

Fit-for-purpose analytical development for an emerging cell therapy landscape

Fit-for-purpose analytical development for an emerging cell therapy landscape

J Wei, D Marshall, F Durst

Flow with confidence: innovations that foster flexibility and scale in closed-system manufacturing

Flow with confidence: innovations that foster flexibility and scale in closed-system manufacturing

Navigating the transition from research to clinical-scale cell therapy manufacture

Navigating the transition from research to clinical-scale cell therapy manufacture

S Feldman, J Fruehauf, M Ann Santos

Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Srinath Kashi Ranganath

Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

Alex Lei, Sabrina Carmichael

Exploring the advantages of ready-to-use lipid-based gene delivery for gene-modified cell therapy

Exploring the advantages of ready-to-use lipid-based gene delivery for gene-modified cell therapy

Chesney Michels, Claire Guéguen

Optimizing iPSC-derived cell therapy development

Optimizing iPSC-derived cell therapy development

O Farah, M Kennedy, A Becker et al.